Market Share of Global Osteoporosis Drugs Industry
The osteoporosis drugs market is moderately competitive and consists of several major players. Some of the companies currently dominating the market are Pfizer Inc., Eli Lily and Company, F. Hoffmann La Roche, Merck & Co. Inc., Amgen Inc., Radius Health Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline PLC, Novartis International AG, and Actavis PLC. This industry is anticipated to witness intense competition during the forecast period due to the rising incorporation of collaborative strategies among the key players to sustain the competitive position. The other strategies incorporated are high R&D investments, mergers and acquisitions, and agreements for drug development.
Osteoporosis Drugs Market Leaders
Eli Lily and Company
F. Hoffmann La Roche
Pfizer Inc.
Merck & Co. Inc.
Amgen Inc.
*Disclaimer: Major Players sorted in no particular order
